Diabetes-induced oxidative stress and low-grade inflammation in porcine coronary arteries

Circulation

Volumn 108, Issue 4, 2003, Pages 472-478

  Zhang, LiFeng ^a   Zalewski, Andrew ^a,b   Liu, Yuchuan ^a   Mazurek, Tomasz ^a   Cowan, Scott ^a   Martin, Jack L ^c   Hofmann, Susanna M ^d   Vlassara, Helen ^d   Shi, Yi ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b GLAXOSMITHKLINE   (United States)

^c BRYN MAWR HOSPITAL   (United States)

^d MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Atherosclerosis; Diabetes mellitus; Inflammation

Indexed keywords

ACETYLCYSTEINE; ADVANCED GLYCATION END PRODUCT; GLUCOSE; INTERLEUKIN 6; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MONOCYTE CHEMOTACTIC PROTEIN 1; PYRROLIDINE DITHIOCARBAMATE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; STRESS ACTIVATED PROTEIN KINASE; SUPEROXIDE; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

ADVENTITIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY MEDIA; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; DIABETES MELLITUS; ENZYME ACTIVITY; FEMALE; FIBROBLAST; GENE EXPRESSION; INFLAMMATION; LEUKOCYTE ADHERENCE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; STREPTOZOCIN DIABETES; SWINE;

ANIMALS; CELLS, CULTURED; CORONARY ARTERIOSCLEROSIS; CORONARY VESSELS; DIABETES MELLITUS, EXPERIMENTAL; DISEASE MODELS, ANIMAL; FEMALE; FIBROBLASTS; GLYCOSYLATION END PRODUCTS, ADVANCED; INFLAMMATION; INFLAMMATION MEDIATORS; MITOGEN-ACTIVATED PROTEIN KINASES; NADH, NADPH OXIDOREDUCTASES; NADPH OXIDASE; OXIDATIVE STRESS; PHOSPHORYLATION; PROTEIN SUBUNITS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIGNAL TRANSDUCTION; STREPTOZOCIN; SUPEROXIDES; SWINE; TUNICA MEDIA;

EID: 0043166481     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000080378.96063.23     Document Type: Article

References (38)

1. Mokdad AH, Bowman BA, Ford ES, et al. The continuing epidemics of obesity and diabetes in the United States. JAMA. 2001;286:1195-1200.
2. Beckman JA, Creager MA, Libby P. Diabetes and atherosclerosis: epidemiology, pathophysiology, and management. JAMA. 2002;287:2570-2581.
3. Gu K, Cowie CC, Harris MI. Diabetes and decline in heart disease mortality in US adults. JAMA. 1999;281:1291-1297.
4. Haffner SM, Lehto S, Ronnemaa T, et al. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med. 1998;339:229-234.
5. Mak K-H, Moliterno DJ, Granger CB, et al. Influence of diabetes mellitus on clinical outcome in the thrombolytic era of acute myocardial infarction. J Am Coll Cardiol. 1997;30:171-179.
6. Malmberg K, Yusuf S, Gerstein HC, et al. Impact of diabetes on long-term prognosis in patients with unstable angina and non-Q-wave myocardial infarction: results of the OASIS Registry. Circulation. 2000;102:1014-1019.
7. Libby P, Plutzky J. Diabetic macrovascular disease: the glucose paradox? Circulation. 2002;106:2760-2763.
8. Coutinho M, Gerstein HC, Wang Y, et al. The relationship between glucose and incident cardiovascular events. Diabetes Care. 1999;22:233-240.
9. Bavenholm P, Proudler A, Tornvall P, et al. Insulin intact and split proinsulin, and coronary artery disease in young men. Circulation. 1995;92:1422-1429.
10. Alexander CM, Landsman PB, Teutsch SM. Diabetes mellitus, impaired fasting glucose, atherosclerotic risk factors, and prevalence of coronary heart disease. Am J Cardiol. 2000;86:897-902.
11. Haffner SM. Epidemiological studies on the effects of hyperglycemia and improvement of glycemic control on macrovascular events in type 2 diabetes. Diabetes Care. 1999;22:C54-C56.
12. Vlassara H. Recent progress in advanced glycation end products and diabetic complications. Diabetes. 1997;46:S19-S25.
13. Schmidt AM, Hori O, Chen JX, et al. Advanced glycation endproducts interacting with their receptor induce expression of vascular cell adhesion molecule-1 (VCAM-1) in cultured human endothelial cells and in mice. J Clin Invest. 1995;96:1395-1403.
14. Basta G, Lazzerini G, Massaro M, et al. Advanced glycation end products activate endothelium through signal-transduction receptor RAGE: a mechanism for amplification of inflammatory responses. Circulation. 2002;105:816-822.
15. Pagano PJ, Clark JK, Cifuentes-Pagano ME, et al. Localization of a constitutively active, phagocyte-like NADPH oxidase in rabbit aortic adventitia: enhancement by angiotensin II. Proc Natl Acad Sci USA. 1997;94:14483-14488.
16. Wang HD, Pagano PJ, Du Y, et al. Superoxide anion from the adventitia of the rat thoracic aorta inactivates nitric oxide. Circ Res. 1998;82:810-818.
17. Shi Y, Niculescu R, Wang D, et al. Increased NAD(P)H oxidase and reactive oxygen species in adventitial fibroblasts after coronary injury. Arterioscler Thromb Vasc Biol. 2001;21:739-745.
18. 2α and platelet activation in diabetes mellitus: effects of improved metabolic control and vitamin E supplementation. Circulation. 1999;99:224-229.
19. Haffner SM, Greenberg AS, Weston WM, et al. Effect of rosiglitazone treatment on nontraditional markers of cardiovascular disease in patients with type 2 diabetes. Circulation. 2002;106:679-684.
20. Patel S, Shi Y, Niculescu R, et al. Characteristics of coronary smooth muscle cells and adventitial fibroblasts. Circulation. 2000;101:524-532.
21. Niwa T, Katsuzaki T, Miyazaki S, et al. Immunohistochemical detection of imidazolone, a novel advanced glycation end product, in kidneys and aortas of diabetic patients. J Clin Invest. 1997;99:1272-1280.
22. Ling X, Nagai R, Sakashita N, et al. Immunohistochemical distribution and quantitative biochemical detection of advanced glycation end products in fetal to adult rats and in rats with streptozotocin-induced diabetes. Lab Invest. 2001;81:845-861.
23. Anderson MM, Requena JR, Crowley JR, et al. The myeloperoxidase system of human phagocytes generates Nepsilon-(carboxymethyl)lysine on proteins a mechanism for producing advanced glycation endproducts at sites of inflammation. J Clin Invest. 1999;104:103-113.
24. Wautier MP, Chappey O, Corda S, et al. Activation of NAD(P)H oxidase by AGE links oxidant stress to altered gene expression via RAGE. Am J Physiol Endocrinol Met. 2001;280:E685-E694.
25. Griendling KK, Sorescu D, Ushio-Fukai M. NAD(P)H oxidase: role in cardiovascular biology and disease. Circ Res. 2000;86:494-501.
26. Park L, Raman KG, Lee KJ, et al. Suppression of accelerated diabetic atherosclerosis by soluble receptor for AGE (sRAGE). Nat Med. 1998;4:1025-1031.
27. Bucciarelli LG, Wendt T, Qu W, et al. RAGE blockade stabilizes established atherosclerosis in diabetic apolipoprotein E-null mice. Circulation. 2002;106:2827-2835.
28. Zalewski A, Shi Y, Johnson AG. Diverse origin of intimal cells: smooth muscle cells, myofibroblasts, fibroblasts, and beyond? Circ Res. 2002;91:652-655.
29. Shi Y, Niculescu R, Chung W, et al. Role of matrix metalloproteinases and their tissue inhibitors in the regulation of coronary cell migration. Arterioscler Thromb Vasc Biol. 1999;19:1150-1155.
30. Shimokawa H, Ito A, Fukumoto Y, et al. Chronic treatment with interleukin-1β induces coronary intimal lesions and vasospastic responses in pigs in vivo. J Clin Invest. 1996;97:769-776.
31. Miyata K, Shimokawa H, Kandabashi T, et al. Rho-kinase is involved in macrophage-mediated formation of coronary vascular lesions in pigs in vivo. Arterioscler Thromb Vasc Biol. 2000;20:2351-2358.
32. O'Brien KD, McDonald TO, Chait A, et al. Neovascular expression of E-selectin, intracellular adhesion molecule-1, and vascular adhesion molecule-1 in human atherosclerosis and their relation to intimal leukocyte content. Circulation. 1996;93:672-682.
33. Kohchi K, Takebayashi S, Hiroki T, et al. Significance of adventitial inflammation in patients with unstable angina: results at autopsy. Circulation. 1985;71:709-716.
34. Kolodgie FD, Virmani R, Cornhill F, et al. Increase in atherosclerosis and adventitial mast cells in cocaine abusers: an alternative mechanism of cocaine-associated coronary vasospasm and thrombosis. J Am Coll Cardiol. 1991;17:1553-1560.
35. Laine P, Kaartinen M, Penttila A, et al. Association between myocardial infarction and the mast cells in the adventitia of the infarct-related coronary artery. Circulation. 1999;99:361-369.
36. Festa A, D'Agostino R Jr, Howard G, et al. Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS). Circulation. 2000;102:42-47.
37. Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation. 2002;105:1135-1143.
38. Ridker PM, Rifai N, Pfeffer MA, et al. Long-term effects of pravastatin on plasma concentration of C-reactive protein. Circulation. 1999;100:230-235.